Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety - AAP
publications.aap.orgSubmitted by aaporg5212 in health
10.1542/6331566750112Video AbstractPEDS-VA_2022-0609936331566750112BACKGROUND AND OBJECTIVES:. The 9-valent human papillomavirus (9vHPV) vaccine Phase III immunogenicity study in 9- to 15-year-old boys and girls was extended to assess immunogenicity and effec…